XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.3
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
SCHEDULE OF STOCK OPTION

A summary of the stock option activity under the Company’s incentive plan for the nine months ended September 30, 2024 is presented below:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Grant Date Fair Value   Weighted Average Remaining Contractual Term (years)   Aggregate Intrinsic Value 
Outstanding at December 31, 2023   30,329   $57.17   $77.22    3.4   $ 
Granted      $   $          
Forfeited   (7,247)  $39.35   $54.02          
Outstanding at September 30, 2024   23,082   $62.77   $84.51    2.6   $ 
                          
Exercisable at September 30, 2024   22,145   $65.30   $87.98    2.2   $ 
SCHEDULE OF RESTRICTED STOCK UNITS AND AWARDS ACTIVITY

The Company’s activity in restricted stock units was as follows for the nine months ended September 30, 2024:

 

   Number of shares   Weighted average fair value 
Non-vested at December 31, 2023   140,491   $28.97 
Granted   251,500   $0.85 
Forfeited   (9,750)  $2.87 
Vested   (30,625)  $22.22 
Non-vested at September 30, 2024   351,616   $10.17 
SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS

The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods:

 

Stock-based compensation expense for RSUs:  2024   2023   2024   2023 
   Three Months Ended September   Nine Months Ended September 
Stock-based compensation expense for RSUs:  2024   2023   2024   2023 
General and administrative  $162,042   $101,607   $476,513   $946,851 
Research and development   207,158    226,646    620,057    691,514 
Total  $369,200   $328,253   $1,096,570   $1,638,365 
SCHEDULE OF WARRANTS OUTSTANDING

The following table summarizes information about shares issuable under warrants outstanding at September 30, 2024:

 

   Warrant shares outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at December 31, 2023   2,799,213   $11.79    4.6   $ 
Expired   (585)   160.00       $ 
Exercised   (1,954,000)   1.37       $ 
Outstanding at September 30, 2024   844,628   $35.78    3.0   $ 
                     
Exercisable at September 30, 2024   844,628   $35.78    3.0   $ 
SCHEDULE OF INVESTMENT OPTIONS

The following table summarizes information about investment options outstanding at September 30, 2024:

 

   Investment options outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at December 31, 2023   70,000   $10.00    4.1   $ 
Outstanding at September 30, 2024   70,000   $10.00    2.9   $ 
                     
Exercisable at September 30, 2024   70,000   $10.00    2.9   $